Although mutations in ATRX and the TERT promoter are mutually exclusive, the coexistence of ALT and telomerase activity has been observed in some tumors, including neuroblastoma [31], sarcoma [32], breast cancers [33] and pHGG [21]. This evidence concerns the gene ATRX and neuroblastoma.